We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Researchers Develop World’s First AI-Augmented Ova and Parasite Detection Tool

By LabMedica International staff writers
Posted on 29 Aug 2019
ARUP Laboratories (Salt Lake City, UT, USA), a national reference laboratory engaged in innovative laboratory research and development, and Techcyte (Lindon, UT, USA), a developer of artificial intelligence (AI) based image analysis solutions for the diagnostics industry, have developed the world’s first AI-augmented ova and parasite detection tool.

ARUP, a national clinical and anatomic pathology reference laboratory, is a non-profit enterprise of the University of Utah and offers an extensive test menu of highly complex and unique medical tests. Techcyte, which was founded as a technology transfer from the University of Utah, uses the power of deep machine learning to perform image analysis of whole slide images. Techcyte’s digital diagnostics platform applies the latest in convolutional neural networks to pre-classify the fecal sample images captured by a 3DHISTECH Pannoramic 250-Flash III scanner. Pre-classifying the images using the Techcyte tool allows ARUP’s technologists to efficiently read stained glass slides manually and improves the accuracy of parasite detection.

Image: ARUP Laboratories and Techcyte have developed the world’s first AI-augmented ova and parasite detection tool (Photo courtesy of Techcyte).
Image: ARUP Laboratories and Techcyte have developed the world’s first AI-augmented ova and parasite detection tool (Photo courtesy of Techcyte).

For laboratorians, digitally enabling the workflow will decrease the physical demands of looking through a microscope for extended periods of time, including eye fatigue and neuromuscular tension. The technology can quickly screen out negative results, allowing laboratorians to spend more time analyzing positive slides. The ova and parasite tool is the first among several projects being co-developed by ARUP and Techcyte. ARUP’s medical expertise and access to samples, combined with Techcyte’s technical ability and digital evaluation platform, will produce high quality algorithms that can be developed and applied to future unmet laboratory needs.

“The collaboration with Techcyte has produced an AI-augmented detection tool that significantly advances our diagnostic capabilities in our parasitology lab,” said Adam Barker, PhD, director of Research and Development at ARUP. “This will allow for faster turnaround times, decreased costs, employee satisfaction and improved patient care.”

“Microscopy-based diagnostic parasitology has remained woefully static for decades. We have successfully developed a pioneering breakthrough with this tool, the likes of which had previously been unimaginable by classically trained microbiologists,” said Dr. Marc Couturier, medical director of ARUP’s Parasitology labs.

“This revolutionary partnership will combine ARUP’s vast expertise and reputation in the market with Techcyte’s AI-based image analysis capabilities to change the way lab diagnostics are performed,” said Ralph Yarro, CEO of Techcyte.

Related Links:
ARUP Laboratories
Techcyte


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
New
Chemistry Analyzer
MS100

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests